Ovid Therapeutics
OVID
#9931
Rank
NZ$35.94 M
Marketcap
$0.51
Share price
-6.57%
Change (1 day)
-90.55%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2023 (TTM): -$1.15

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.26. In 2022 the company made an earnings per share (EPS) of -$1.38 a decrease over its 2021 EPS that were of $3.18.

EPS history for Ovid Therapeutics from 2016 to 2023

201720182019202020212022-$4-$2$2$40companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$1.15-16.99%
2022-$1.38-143.5%
2021$3.18-226.43%
2020-$2.51-11.39%
2019-$2.84-25.47%
2018-$3.81-23.94%
2017-$5.00143.74%
2016-$2.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.91 211.43%๐Ÿ‡บ๐Ÿ‡ธ USA